Clinical Trials · NCT00990535
High Dose Somatostatin Analogues in Neuroendocrine Tumors
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Federico II University
- Enrollment
- 28
- Start date
- Jan 2006
- Locations
- 1 site, Italy
- Primary endpoint
- Tumor stabilization